Abeona therapeutics initiates pivotal phase 3 clinical trial evaluating eb-101 gene therapy for recessive dystrophic epidermolysis bullosa

Study open for enrollment and patient screening underway at stanford university
ABEO Ratings Summary
ABEO Quant Ranking